Table 5.
Controls (n = 20) |
Women with IH (n = 12) |
Women with PCOS (n = 10) |
p-Value | |
---|---|---|---|---|
∑parabens | 0.013 (0.013–0.081) | 0.0395 (0.013–0.753) | 0.013 (0.013–0.087) | 0.448 |
MP [ng/mL] | 0.013 (0.013–0.070) | 0.0395 (0.013–0.583) | 0.013 (0.013–0.072) | 0.405 |
MP occurrence (%) | 35 | 58 | 40 | |
BPA [ng/mL] | 0.123 (0.041–0.289) | 0.107 (0.092–0.162) | 0.053 (0.014–0.113) | 0.234 |
BPA occurrence (%) | 85 | 92 | 60 | |
BPS [ng/mL] | 0.028 (0.011–0.039) | 0.011 (0.011–0.039) | 0.035 (0.028–0.051) | 0.465 |
BPS occurrence (%) | 65 | 50 | 90 | |
oxybenzone [ng/mL] | 0.014 (0.014–0.053) | 0.014 (0.014–0.054) | 0.014 (0.014–0.039) | 0.938 |
oxybenzone occurrence (%) | 35 | 33 | 30 |
Abbreviations: MP—methylparaben, BPA—bisphenol A, BPS—bisphenol S.